Express News | FSD Pharma Shares Are Trading Higher After the Company Entered Into an Exclusive Option Agreement With the University of Southern California to Evaluate Dietary Supplement Technology for Commercialization
Express News | FSD Pharma Enters Exclusive Option Agreement With University Of Southern California To Evaluate Dietary Supplement Technology For Commercialization
Weekly Roundup on the Cannabis Sector & Psychedelic Sector Week of 6/2/24
FSD Pharma Clinches $3M Victory in Arbitration
Express News | FSD Pharma Submits Clinical Trial Protocol To Assess Safety And Efficacy Of Unbuzzd
FSD Pharma Boosts Investor Engagement
Express News | Shares of Cannabis Stocks Are Trading Higher After Biden Said the Justice Department Is Taking the Next Steps to Reclassify Marijuana From Schedule I to Schedule III
Express News | President Biden Posts On X "Too Many Lives Have Been Upended Because Of Our Failed Approach To Marijuana. So Today, The @TheJusticeDept Is Taking The Next Step To Reclassify Marijuana From A Schedule I To A Schedule Iii Drug Under Federal Law."
FSD Pharma Unveils Unbuzzd's Fresh New Look
FSD Pharma | 6-K: Report of foreign private issuer (related to financial reporting)
Express News | 'DEA Appears To Question Marijuana's Medical Value Despite Rescheduling Recommendation' - Marijuana Moment
FSD Pharma Advances MS Treatment Trials
Newsweek Reporter Kevin Sabet Says On X "I Can Now Say With Full Confidence That The Administrator Of DEA, Anne Milgram, Did Not Sign The Rescheduling Order, Breaking With Five Decades Of Precedent And Established Law And Regulations (Two Confidential...
Newsweek Reporter Kevin Sabet Says On X "I Can Now Say With Full Confidence That The Administrator Of DEA, Anne Milgram, Did Not Sign The Rescheduling Order, Breaking With Five Decades Of Precedent An
Express News | 'Declassifying Cannabis Still Leaves Pot Stocks In Limbo' - Wall Street Journal
FSD Pharma Trials Supplement for Alcohol Intoxication
DEA Moving To Reclassify Marijuana As Less Dangerous Drug
DEA Moving To Reclassify Marijuana As Less Dangerous Drug
FSD Pharma Signs Agreement With Applied Science And Performance Institute To Conduct A Clinical Trial In The U.S. To Assess The Safety And Efficacy Of 'Unbuzzd' In An Induced State Of Alcohol Intoxication
FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" of the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the trea
Express News | Watching Shares Of Marijuana Stocks; Traders Circulate Comments From The TDR Podcast Saying "We've Heard Rumors That Potentially That Announcement Could Be Coming This Week - Whatever The Decision May Be", "I'm Hearing From Some Sources That Pro-Marijuana
FSD Pharma Says Celly Nutrition Partners With Six+One for US Launch of Dietary Supplement
FSD Pharma (HUGE) said Thursday that Celly Nutrition has partnered with branding agency Six+One to collaborate on the launch of its dietary supplement unbuzzd in the US. As part of the collaboration,
FSD Pharma's Unbuzzd Gears Up for U.S. Launch
No Data